24.09

1.11% -0.27

CervoMed Inc (CRVO)

Overview News Price History Discussions Forecast Stock Split

CervoMed Inc stock is currently priced at $24.09, with a 24-hour trading volume of 20,929. It has seen a -1.11% decreased in the last 24 hours and a -3.64% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $24.66 pivot point. If it approaches the $23.69 support level, significant changes may occur.

Previous Close:

$24.36

Open:

$24.72

24h Volume:

20,929

Market Cap:

$198.83M

Revenue:

Net Income/Loss:

$-6.42M

P/E Ratio:

-2.5252

EPS:

-9.54

Net Cash Flow:

$-7.45M

1W Performance:

-2.31%

1M Performance:

-3.64%

6M Performance:

+144.07%

1Y Performance:

+0.00%

1D Range:

$23.69

$24.80

52W Range:

$4.28

$26.38

CervoMed Inc Stock (CRVO) Company Profile

Name

CervoMed Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

617-744-4400

Address

20 Park Plaza, Suite 424, Boston

Employee

Twitter

Next Earnings Date

2024-06-14

Latest SEC Filings

CRVO's Discussions on Twitter

CervoMed Inc Stock (CRVO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-17-20	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-21-18	Initiated	H.C. Wainwright	Buy

CervoMed Inc Stock (CRVO) Latest News

CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

GlobeNewswire

CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates - Yahoo Finance

Yahoo Finance

Short Interest in CervoMed Inc. (NASDAQ:CRVO) Increases By 101.6% - MarketBeat

MarketBeat

CervoMed Inc expected to post a loss of 39 cents a share - Earnings Preview - XM

Cwm LLC Invests $292,000 in CervoMed Inc. (NASDAQ:CRVO) - MarketBeat

MarketBeat

Cwm LLC Invests $292,000 in CervoMed Inc. (NASDAQ:CRVO) - MarketBeat

MarketBeat

CervoMed Inc Stock (CRVO) Financials Data

CervoMed Inc (CRVO) Net Income 2024

CRVO net income (TTM) was -$6.42 million for the quarter ending December 31, 2023, a +42.33% increase year-over-year.

CervoMed Inc (CRVO) Cash Flow 2024

CRVO recorded a free cash flow (TTM) of -$7.45 million for the quarter ending December 31, 2023, a +50.23% increase year-over-year.

CervoMed Inc (CRVO) Earnings per Share 2024

CRVO earnings per share (TTM) was -$5.6013 for the quarter ending December 31, 2023, a +49.40% growth year-over-year.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.